about
Prevalence of human papillomavirus genotypes in HIV-1-infected women in Seattle, USA and Nairobi, Kenya: results from the Women's HIV Interdisciplinary Network (WHIN)Cervical dysplasia and high-risk human papillomavirus infections among HIV-infected and HIV-uninfected adolescent females in South Africa.Blunt diaphragmatic injury in a 7-year-old girl.Incidental Findings of Bacterial Vaginosis and Other Infections in Papanicolaou Smears of HIV-infected and HIV-uninfected Adolescent Females in South AfricaIncreased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAARTInclusion of South African adolescents in HIV vaccine trials.Perspectives of South American physicians hosting foreign rotators in emergency medicine.Surfing USA: an epidemiological study of surfing injuries presenting to US EDs 2002 to 2013.Emergency department opioid pain medication prescribing: Influence of patient satisfaction and other factors.The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction.Assessing adherence with preventive screening recommendations among ED patients: Piloting an effective use of wait time.Implementation of an Emergency Medicine Research Associates Program: Sharing 20 Years of Experience.High Rate of Multiple Concurrent Human Papillomavirus Infections among HIV-Uninfected South African AdolescentsRecurrent syncope is not an independent risk predictor for future syncopal events or adverse outcomesPredictors of Short Intensive Care Unit Stay for Patients with Diabetic Ketoacidosis Using a Novel Emergency Department-Based Resuscitation and Critical Care UnitSick and unsheltered: Homelessness as a major risk factor for emergency care utilizationA Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African AdolescentsUltrasound-assisted lumbar puncture in pediatric emergency medicineOutcomes of Patients With Syncope and Suspected DementiaQTc prolongation as a marker of 30-day serious outcomes in older patients with syncope presenting to the Emergency DepartmentComparison of 30-Day Serious Adverse Clinical Events for Elderly Patients Presenting to the Emergency Department With Near-Syncope Versus SyncopeAn Intervention to Increase Uptake of Cervical Cancer Screening Among Emergency Department Patients: Results of a Randomized Pilot StudyRisk Stratification of Older Adults Who Present to the Emergency Department With Syncope: The FAINT ScoreDo High-sensitivity Troponin and Natriuretic Peptide Predict Death or Serious Cardiac Outcomes After Syncope?Emergency physician utilization of transvaginal ultrasound after initiation of revised sterilization protocolPrehospital supplemental oxygen for acute stroke - A retrospective analysisPredictors of Clinically Significant Echocardiography Findings in Older Adults with Syncope: A Secondary AnalysisClinical Benefit of Hospitalization for Older Adults With Unexplained Syncope: A Propensity-Matched AnalysisFrequency of Abnormal and Critical Laboratory Results in Older Patients Presenting to the Emergency Department With SyncopeValidation of the Emergency Severity Index (Version 4) for the Triage of Adult Emergency Department Patients With Active CancerAnalysis of Diagnoses, Symptoms, Medications, and Admissions Among Patients With Cancer Presenting to Emergency DepartmentsOrthostatic vital signs do not predict 30 day serious outcomes in older emergency department patients with syncope: A multicenter observational study
P50
Q34180553-B7F97DE1-4D20-48AD-853B-9EF7EF8EE441Q34441738-25ECBBB0-5246-46E1-8DC9-A10E64DE22E8Q34825662-DB3D3186-B8B8-4A44-A5F3-5A900E8ED2DBQ36306258-388DD0C3-714A-4F17-83D2-A740596E3213Q37006521-279A452E-D4AC-465A-878D-BF1F5E910361Q37698508-D60FC037-4046-4954-BFB7-35484A2FA982Q39045268-D04BE78D-5CA7-4C0C-884D-3D51EB31B724Q39709483-ABB2DE61-C181-4D78-8E94-0AE1A73F7E09Q44349356-492DE12E-FCCC-4727-B383-1B14EC2691D5Q47258737-A3ADFB1B-7E9A-4697-BFAC-1FBF2246C4C4Q49601372-25439E85-1718-49E5-8891-4852FC760291Q55355357-0DF8208F-2B8E-4223-A196-64FFBD9B89CBQ56963267-B1C2C2D3-9770-4787-9A90-DA9F5991FFE6Q58564394-E8026850-4F71-4509-8023-FDAF63AD7D05Q58614317-CE0360AF-27C2-409F-AF3C-0FD2028A20CDQ60920189-91F904F3-8311-4B73-BCE3-01C35479F41FQ86927860-395F80F8-B7C7-429D-AA63-CC34F798A691Q87772372-813359AB-5346-4E85-BAAE-689A6698B831Q88164230-431A74CE-7464-441E-9D65-0A4246B9FF97Q90289693-6BC46112-3FE7-4A59-9068-6EA467B28309Q90356204-732409D8-4E49-4D15-8283-462B1A40062FQ90596575-28290727-7075-4ED2-9BFE-AEF85D2B34B1Q91023500-F9F1CB71-A845-4591-95B2-51ADE96F7D93Q91353438-4F9968B4-E5B8-4386-9F23-04F5DB4D2F57Q91366830-F6428094-D7C6-4FF6-BE04-CF8911289B5AQ91580397-6C077537-D074-4137-B93B-F0061CCC0C10Q91751684-E221EE09-8DD0-4746-B184-1F89BC6C5881Q91958732-562AFE5C-D40F-4A50-9D53-24C41B6BD4B8Q91976988-411056CC-C19C-4A77-95A4-1A3717BD772AQ92230515-4AD5F77D-36D1-43B3-8EC2-40E4B7449E4DQ92551690-AC195644-CAB7-4105-90B1-2720C40CAA2AQ92717984-2BFBF935-6049-4197-A1CD-0A1F67DCDDE2
P50
description
researcher
@en
wetenschapper
@nl
name
David H Adler
@en
David H Adler
@nl
type
label
David H Adler
@en
David H Adler
@nl
prefLabel
David H Adler
@en
David H Adler
@nl
P106
P31
P496
0000-0002-8797-1621